Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the creation of selective receptor modulators, including those targeting neurological disorders such as Parkinson’s disease and schizophrenia. Commonly employed in medicinal chemistry for constructing fused heterocyclic systems that enhance drug potency and metabolic stability. Also utilized in the preparation of kinase inhibitors and other bioactive molecules where fluorinated scaffolds improve binding affinity and pharmacokinetic properties.